688566.SH
吉贝尔
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 25.41
−3.31%Aug 27, 2026, 09:10 UTC
Jibeier announced a cash dividend of 2.6 yuan per 10 shares (tax inclusive), totaling 52.2864 million yuan (tax inclusive).
Source:Aug 27, 2026, 09:10 UTC
Jibeier announced its first-half 2026 results: revenue of 490 million yuan, up 7.61% year-on-year; net profit attributable to shareholders of 99.2384 million yuan, down 33.54% year-on-year; non-recurring net profit of 99.2669 million yuan, down 6.92% year-on-year.
Source:Aug 9, 2026, 07:41 UTC
Jichuan Pharmaceutical's wholly-owned subsidiary Jichuan Pharmaceutical Group Co., Ltd. received drug registration certificates for Pediatric Laxative Granules and Mesalazine Sustained-Release Granules approved and issued by the National Medical Products Administration on August 9, 2026.
Source:Jul 29, 2026, 10:20 UTC
Jibeier received a patent certificate for a new taxane compound preparation method from the China National Intellectual Property Administration on 2026-07-28.
Source: